Related Experiment Video

Updated: Jun 21, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Pathophysiologic mechanisms of anemia of chronic disease

Nancy C Andrews1

  • 1Harvard Medical School, Boston, MA 02115, USA. nandrews@enders.tch.harvard.edu

Postgraduate Medicine
|August 12, 2009
PubMed

Insights

Anemia of chronic disease (ACD) involves complex iron dysregulation. New research highlights the hormone hepcidin

Area of Science:

  • Hematology
  • Internal Medicine
  • Pathophysiology

Background:

  • Anemia of chronic disease (ACD) is common in patients with chronic infections, cancer, and inflammatory disorders.
  • Understanding iron homeostasis is crucial for managing ACD.
  • Hepcidin's role in iron metabolism is a recent area of focus.

Purpose of the Study:

  • To examine new research on the pathophysiologic mechanisms of ACD.
  • To explore the significance of hepcidin in iron metabolism and ACD pathogenesis.
  • To discuss the link between ACD and hereditary hemochromatosis through hepcidin.

Main Methods:

  • Review of iron homeostasis and historical context of ACD.
  • Examination of recent research findings on hepcidin.
  • Analysis of a new hypothesis connecting hepcidin to ACD pathogenesis.

Main Results:

  • Hepcidin plays a significant role in the pathogenesis of ACD.
  • A novel hypothesis links hepcidin to the development of ACD.
  • Hepcidin is implicated in both ACD and hereditary hemochromatosis.

Conclusions:

  • Hepcidin is a key hormone in understanding ACD.
  • Further research into hepcidin's role can lead to better ACD management.
  • Shared pathophysiologic mechanisms involving hepcidin exist between ACD and hereditary hemochromatosis.

More Related Videos

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: